Skip to main content
Medical Reference · Condition Monograph

Spina Bifida

척추이분증

Spina bifida is a collective term for congenital conditions that arise when the spine and spinal cord do not close completely during the fetal period.

History

Spina bifida is a collective term for congenital conditions that arise when the spine and spinal cord do not close completely during the fetal period. In the past, the focus was on severe forms that could be seen externally, such as "a state in which there is an opening in the back and the nerves are exposed," and survival itself was a major problem because of complications such as infection and hydrocephalus right after birth. Later, as antibiotics, anesthesia and intensive care, and neurosurgery developed, treatment to close the defect right after birth became the standard, and hydrocephalus, in which fluid builds up in the brain, became controllable with methods such as ventriculoperitoneal shunting. As a result, many children came to survive into adulthood, and the goal of medical care shifted from "treatment that saves lives" to "treatment that preserves function and quality of life as much as possible."

From the 1990s onward, evidence accumulated that folic acid intake in early pregnancy reduces neural tube defects, and as grain fortification policies were implemented in many countries, the incidence decreased. At the same time, as prenatal ultrasound technology improved, more cases came to be diagnosed during pregnancy, and systems for discussing treatment strategies before birth also developed.

Recently, as fetal surgery (surgery that closes the defect in advance inside the uterus) has become established as an option, research and clinical guidelines on its advantages and disadvantages compared with postnatal surgery have accumulated. Recent studies have reported results showing that fetal surgery can, in some children, reduce the downward displacement of structures at the back of the brain (Chiari II malformation) and the need for shunting, and can improve motor function. However, because the risks to the pregnant woman and the fetus must also be considered, there is growing emphasis on having experienced multidisciplinary teams evaluate the indications strictly.

Causes

The cause of spina bifida is difficult to pin down to a single factor, and it is most realistic to understand that genetic and environmental factors act together. Spina bifida can occur if a problem arises in the process of neural tube closure during the very early stage of pregnancy, usually in a short period around the time a woman learns she is pregnant. A representative environmental factor is folate deficiency. Folate is a vitamin needed during the period when cells divide rapidly and tissues are formed, and intake before pregnancy and in early pregnancy is especially important. Folate deficiency is known to increase the risk of neural tube defects.

In addition, some antiseizure drugs (especially the valproate class), maternal obesity, and uncontrolled diabetes are cited as factors that can raise the risk. High body temperature (severe fever or exposure to high heat) is also mentioned as a factor that can affect fetal development. Conversely, spina bifida can occur even without these risk factors, and having risk factors does not mean it will necessarily occur.

What is clinically important is not so much "identifying the cause" as "strategies to lower the risk in the next pregnancy" and "strategies to predict and manage complications in the current child." If there is a family history (a parent or sibling with a neural tube defect), the risk in the next pregnancy may increase somewhat, so taking sufficient folic acid from the stage of preparing for pregnancy and planning prenatal testing become key.

Genetic Epidemiology

Spina bifida is not a disease explained by heredity alone; it is closer to a "multifactorial disease" in which multiple gene variants and environmental factors act together. A family history raises the risk, but in most patients a clear inheritance pattern does not appear as it does in distinct single-gene diseases. It is generally known that if one child is born with spina bifida, the probability of the same problem occurring in the next pregnancy may be higher than average.

In research, variants have been found in genes involved in the process of neural tube closure, such as the planar cell polarity pathway, and the possibility that various genetic factors related to folate metabolism influence risk has also been discussed. However, current clinical practice has not reached the stage of "accurately predicting the risk of spina bifida with genetic testing."

Genetic knowledge provides an understanding of pathophysiology and a direction for research, but for most families, folic acid intake before pregnancy and standard prenatal screening remain the most practical means of prevention and management. In recent studies, as large-scale genomic analysis technology has advanced, attempts to elucidate gene-environment interactions have increased. As such research accumulates, it may in the long term help classify high-risk groups more finely and propose personalized prevention strategies.

At present, in health management for the general public, universal approaches such as "taking sufficient folic acid from before pregnancy, adjusting risky medications in consultation with a specialist, and managing diabetes and weight" are the most solidly evidence-based.

General Epidemiology

The frequency of spina bifida varies greatly depending on country and region, race and ethnicity, health policies, and access to prenatal diagnosis. One of the factors that makes the biggest difference is folic acid fortification policy and the level of folic acid intake before pregnancy. In regions where policies of fortifying grains with folic acid have been implemented, the occurrence of neural tube defects has decreased. Conversely, in places without fortification policies or with low access to nutrition, the burden remains high.

Spina bifida is broadly divided into a hidden form covered by skin that is not readily apparent externally (spina bifida occulta) and an open form in which neural tissue is exposed or protrudes as a cyst (especially myelomeningocele). The hidden form often has almost no symptoms and is often discovered incidentally, and depending on the statistics, it is reported as fairly common. The open form, on the other hand, requires surgery and long-term management from right after birth, placing a heavy burden on health care.

Recent studies emphasize that the prognosis can differ not only between countries but also within the same country depending on access to medical care, socioeconomic status, and the level of care before pregnancy. Survival and function can improve with appropriate surgery right after birth, management of hydrocephalus, and urological and rehabilitation treatment, but in regions lacking such systems, mortality and the burden of disability can increase because of complications such as infection, pressure ulcers, and decline in kidney function. Therefore, when understanding the general epidemiology, it is important to consider not only "the occurrence of the disease" but also "the differences in long-term outcomes created by treatment systems."

Pathogenesis

Spina bifida arises when a structure called the "neural tube" does not close completely at a very early stage of fetal formation. The neural tube is a cylindrical structure that later becomes the brain and spinal cord, and in normal development it is completed as it gradually closes from front to back in early pregnancy. If a problem arises in this process, a neural tube defect develops, and a defect arising on the spinal side is spina bifida. Because the defect arises at a very early point, the recommendation is made to "take folic acid from the time of preparing for pregnancy."

In the open form (myelomeningocele), the explanation that damage can progress over time as neural tissue is exposed to the amniotic fluid has been widely accepted. In other words, it is the concept that neurological function can worsen as additional damage (the second hit), such as exposure to amniotic fluid and mechanical irritation, is added on top of the initial defect (the first hit). In recent studies, this view has often been mentioned as the theoretical basis for fetal surgery.

Another important associated mechanism is the problem of pressure and flow in the brain and spinal cord. When there is a spinal cord defect, a change in which structures at the back of the brain are pulled downward (Chiari II malformation) sometimes accompanies it, and this can block the flow of cerebrospinal fluid and cause hydrocephalus. Because hydrocephalus can cause brain damage and developmental problems, it is important to control it at the appropriate time with shunting or other methods. In addition, over time, "tethered cord," in which the spinal cord becomes attached to surrounding tissue and is pulled, can develop and become a cause of worsening neurological function during the growth period or in adulthood.

Symptoms

The symptoms of spina bifida vary greatly depending on "what form it is (hidden or open)" and "where the lesion is located (at what level of the spine)." In the hidden form, there may be almost no outward sign, or clues may be seen on the skin of the lower back, such as a small dimple, a hairy patch, pigmentation, or a small swelling. In this case, many people may have no symptoms throughout life. However, in some, neurological symptoms such as low back pain, numbness in the legs, foot deformities, and bladder and bowel problems may appear as they grow.

In the open form (myelomeningocele), distinct neurological problems are likely to appear from right after birth. Typically, the legs are weak or paralyzed, sensation is dulled, and walking may be difficult or braces or a wheelchair may be needed. In addition, the nerve functions that control the bladder and bowel are damaged, which can lead to urinary incontinence, fecal incontinence, recurrent urinary tract infections, and decline in kidney function. Orthopedic problems are also common, and equinus (a deformity in which the foot is fixed pointing downward), hip dislocation, and scoliosis may accompany it.

Brain-related symptoms are also important. If hydrocephalus develops, symptoms such as rapid enlargement of head circumference, vomiting, fussiness, and decreased consciousness may appear. Learning problems vary greatly between individuals, but when hydrocephalus is present and a shunt has been placed, difficulties in specific areas such as attention, executive function, and mathematics have been reported. Recent studies have emphasized that, rather than the simplistic expression "the child's intelligence is low overall," the pattern of specific cognitive functions and support strategies in daily life are what matter.

Signs

The signs that the medical team can observe can be broadly divided into external signs of the skin and spine, neurological signs, and urological and orthopedic signs. In the open form, a sac covered by a membrane (meningocele) or a defect with exposed neural tissue may be seen in the lower back or sacral area, and because this carries a high risk of infection, protection and surgical planning are needed right after birth. In the hidden form, skin clues (dimple, hair, hemangioma, pigmented lesion, subcutaneous mass) are important, and when such clues are present, associated abnormalities such as tethered cord, lipoma, and split cord malformation can be suspected.

Neurological signs include weakness of the leg muscles, abnormal muscle tone, changes in reflexes, decreased sensation, and gait abnormalities. Because the muscles and functions affected differ depending on the level of the lesion, identifying on neurological examination "at which neurological level function is reduced" helps predict prognosis and plan rehabilitation. When symptoms worsen with growth, this may be a sign that tethered cord is progressing, so changes in symptoms over time are important.

Urological signs are not readily visible, but they have a major impact on long-term prognosis. If there are findings such as urinary incontinence, residual urine, recurrent urinary tract infections, or kidney dilation, neurogenic bladder is suspected. Even if these problems begin with mild symptoms, they can damage kidney function over time, so systematic evaluation and management are needed from childhood and adolescence. Latex allergy is also reported relatively often, and it is known that caution is needed because of its association with repeated surgeries and procedures.

Screening

Screening for spina bifida can be divided mainly into prenatal screening performed during pregnancy and screening evaluation performed after birth in children with skin clues. In prenatal screening, the risk may be increased when the alpha-fetoprotein level is high on the maternal serum test performed in the second trimester (usually around 15–20 weeks). However, this test is "a test that indicates a higher likelihood," not a confirmatory test. Ultrasound helps detect the open form not only through the defect in the spine itself but also through indirect findings such as changes in the shape of the skull.

The information that can be observed on ultrasound differs depending on the week of pregnancy. The spinal defect and associated findings are usually evaluated on a detailed second-trimester ultrasound, and if necessary, fetal magnetic resonance imaging may be used to confirm the location and extent of the lesion in more detail. Recent studies have reported attempts at early detection using specific ultrasound markers even in the first trimester. Realistically, however, the detailed second-trimester ultrasound remains established as the key screening step.

After birth, the open form is visible to the naked eye, so "screening" is not needed, but the hidden form is easily missed. When there are clues on the skin of the lower back such as a dimple, hair, hemangioma, or mass, evaluation for an associated spinal cord abnormality is recommended. In infants, spinal ultrasound can be helpful, and later, magnetic resonance imaging is used for more accurate evaluation. Because the purpose of screening is "to find warning signs before symptoms develop and prevent nerve damage," it is important not to take skin clues lightly.

Diagnosis

Diagnosis can be divided into prenatal diagnosis and postnatal diagnosis. Prenatally, ultrasound is the most basic tool, and in the open form, indirect findings in the head can be confirmed along with the spinal defect. The alpha-fetoprotein level on the maternal serum test is sometimes high, which can prompt an ultrasound evaluation. If necessary, alpha-fetoprotein or other markers may be checked through amniocentesis, but in actual clinical practice, ultrasound and fetal magnetic resonance imaging are the key tools that provide anatomical information.

After birth, the key to the diagnostic process is confirming the form of the lesion and systematically evaluating associated abnormalities and complications. Because magnetic resonance imaging can show the spinal cord and surrounding tissues in detail, it is especially useful for identifying associated lesions in the hidden form, such as tethered cord, lipoma, split cord malformation, and arachnoid cysts. Computed tomography and plain x-rays help in viewing bone structures but have limitations in viewing the spinal cord itself.

In spina bifida, "diagnosis" does not end with imaging. A practical treatment plan is completed only when neurological evaluation (strength, sensation, reflexes, gait), urological evaluation (urodynamic testing, kidney and bladder ultrasound, and others), orthopedic evaluation (joint deformities, scoliosis), and brain evaluation (presence of hydrocephalus, Chiari II malformation, and others) are carried out together. Recent studies have emphasized that as long-term survival increases, systematic evaluation items and follow-up management are important in transition care after adolescence (the process of moving from pediatric to adult care).

Treatment

It helps understanding to think of treatment as divided into "surgery to close the defect" and "lifelong management of complications." In the open form, it is common to perform surgery to close the defect as soon as possible after birth in order to prevent infection and protect the neural tissue. In some cases, a method of closing the defect in advance with fetal surgery during pregnancy may also be chosen. Fetal surgery may improve some outcomes, but because it carries risks such as preterm birth, rupture of membranes, and maternal complications, it is not a treatment applied in every case.

If hydrocephalus is present, shunting to drain cerebrospinal fluid or other treatment may be needed. Shunting helps control intracranial pressure, but complications such as blockage and infection can occur, so long-term follow-up is needed. For tethered cord, surgical release is considered when symptoms worsen during growth. Orthopedic problems are corrected with braces, physical therapy, and, if necessary, surgery, and rehabilitation is key to maintaining muscle strength, preventing joint contractures, and improving mobility.

Urological management is a central pillar of treatment. If neurogenic bladder is present, the goal is to protect kidney function through clean intermittent catheterization, drug therapy, control of bladder pressure, and infection prevention strategies. Bowel dysfunction is approached step by step, including a bowel program, dietary and medication adjustment, and, if necessary, surgical methods.

Skin care (pressure ulcer prevention), latex allergy prevention, and learning and psychological support are also important components of long-term treatment. Recent studies have pointed out that support in areas such as employment, independent living, and mental health is lacking by the time people reach adulthood, and discussion continues about the importance of multidisciplinary clinics and transition care models.

Prognosis

The prognosis depends on the form and level of the lesion, associated brain abnormalities such as hydrocephalus and Chiari II malformation, kidney function, the quality of early surgery and rehabilitation, social support, and other factors. In the open form, the higher the lesion is on the spine, the greater the loss of leg function, and more assistance with mobility may be needed. On the other hand, when the lesion is lower, some children may be able to walk with braces or crutches. However, rather than dividing the prognosis simply into "walks / does not walk," it is important to recognize that function can change during growth and that management of complications has a major influence on quality of life.

In the long term, the most important prognostic factor is kidney function. If neurogenic bladder is not properly managed, recurrent urinary tract infections, reflux, and kidney damage can accumulate. Conversely, if it is systematically evaluated from early on and clean intermittent catheterization and drug therapy are used appropriately, the likelihood of living into adulthood while maintaining good kidney function increases. Secondary problems such as pressure ulcers, scoliosis, fractures, and obesity also affect the prognosis.

The cognitive and learning domain varies greatly between individuals and can be influenced by hydrocephalus and whether related treatment (e.g., shunting) was received. Recent studies have emphasized that difficulties may appear in specific cognitive functions (attention, planning and organization, working memory, and others) and that concrete support at school and at home is needed. Because changes in the health care system and the burden of self-management increase in the transition to adulthood, whether the transition care process is well established can also be seen as part of the prognosis.

Prevention

The most solid evidence for prevention is folic acid intake before pregnancy and in early pregnancy. Because the neural tube closes at a very early point in early pregnancy, it is important to take folic acid from the stage of planning a pregnancy. Generally, a set daily amount of folic acid is recommended for women of childbearing age, and a higher dose may be recommended for those who have previously given birth to a child with a neural tube defect or who have certain risk factors. In addition, public health policies that fortify grains with folic acid are known to be effective in reducing neural tube defects at the population level.

Management of medications and underlying conditions is also central to prevention. Because some antiseizure drugs can raise the risk, when planning a pregnancy it is necessary to consult neurology and obstetrics and gynecology and to consider medication adjustment together with folic acid supplementation. If diabetes is present, it is important to control blood glucose well from before pregnancy, and because obesity can be associated with the risk of neural tube defects as well as various pregnancy complications, weight management is helpful.

Recent studies have suggested that "folate-resistant" cases not explained by folic acid alone may exist, and that environmental exposures and genetic vulnerability may act in combination. Even so, the center of currently practicable prevention strategies still rests on four pillars: folic acid intake, management of risky medications, management of diabetes and weight, and standard prenatal screening. Because prevention is difficult to accomplish through individual effort alone, the most realistic approach is to make a plan together with the medical team at the stage of preparing for pregnancy.

This content is provided for general medical information only and does not replace individual diagnosis or treatment. If symptoms persist, please consult a medical professional.